NCT-SEED-001Phase 3Recruiting
Semaglutide Cardiovascular Outcomes Trial
Phase
Phase 3
Enrollment
4,200
Location
United States
Trial information
- Registry ID
- NCT-SEED-001
- Status
- Recruiting
- Phase
- Phase 3
- Sponsor
- Lumin Research Network
- Country
- United States
- Target enrollment
- 4,200